[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1931309T3 - Antimykotisk sammensætning - Google Patents

Antimykotisk sammensætning

Info

Publication number
DK1931309T3
DK1931309T3 DK06793874.6T DK06793874T DK1931309T3 DK 1931309 T3 DK1931309 T3 DK 1931309T3 DK 06793874 T DK06793874 T DK 06793874T DK 1931309 T3 DK1931309 T3 DK 1931309T3
Authority
DK
Denmark
Prior art keywords
antimycotic composition
antimycotic
composition
Prior art date
Application number
DK06793874.6T
Other languages
English (en)
Inventor
Friedrich Karl Mayer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1931309T3 publication Critical patent/DK1931309T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK06793874.6T 2005-09-29 2006-09-27 Antimykotisk sammensætning DK1931309T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72262505P 2005-09-29 2005-09-29
US72316305P 2005-10-03 2005-10-03
PCT/EP2006/066816 WO2007039533A2 (en) 2005-09-29 2006-09-27 Antifungal composition

Publications (1)

Publication Number Publication Date
DK1931309T3 true DK1931309T3 (da) 2013-01-02

Family

ID=37499683

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06793874.6T DK1931309T3 (da) 2005-09-29 2006-09-27 Antimykotisk sammensætning

Country Status (18)

Country Link
US (1) US10525003B2 (da)
EP (1) EP1931309B1 (da)
JP (1) JP5174671B2 (da)
KR (1) KR101333892B1 (da)
AU (1) AU2006298748B2 (da)
BR (1) BRPI0616765A2 (da)
CA (1) CA2623031C (da)
DK (1) DK1931309T3 (da)
ES (1) ES2391409T3 (da)
HK (1) HK1117403A1 (da)
IL (1) IL189858A (da)
NO (1) NO339414B1 (da)
NZ (1) NZ566401A (da)
PL (1) PL1931309T3 (da)
PT (1) PT1931309E (da)
RU (1) RU2417073C2 (da)
SG (1) SG166105A1 (da)
WO (1) WO2007039533A2 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101031568B1 (ko) 2008-05-28 2011-05-04 가부시키가이샤 분쵸우 투명 고형상 마카
JP5654497B2 (ja) * 2009-02-13 2015-01-14 トピカ ファーマシューティカルズ,インコーポレイテッド 抗真菌製剤
RU2485955C2 (ru) * 2010-11-17 2013-06-27 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая флуконазол, и/или кетоконазол, и/или тербинафин и липосомы для местного применения
FR2976806B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition topique filmogene et son utilisation pour le traitement des mycoses
KR101457789B1 (ko) 2013-02-13 2014-11-03 동아제약 주식회사 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법
KR101690765B1 (ko) * 2015-04-17 2016-12-28 동아제약 주식회사 항진균성 활성물질을 포함하는 경피 제제
US11554108B2 (en) 2016-08-29 2023-01-17 Xeropedix, Inc. Methods and compositions for treating cutaneous fungal infections
CN109862882A (zh) * 2016-08-29 2019-06-07 卡尔·F·尚巴赫 用于治疗皮肤真菌感染的方法和组合物
EP3508835A4 (en) * 2016-08-31 2020-04-22 Kabushiki Kaisha Yakult Honsha METHOD FOR PREPARING A SAMPLE FOR ANALYZING OR MONITORING SKIN
FR3064488B1 (fr) * 2017-03-31 2021-01-01 Urgo Rech Innovation Et Developpement Composition contenant un derive de cellulose, un plastifiant, un solvant volatil et un actif, ses utilisations comme pansement

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045914A1 (de) 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
JPH0818983B2 (ja) 1987-12-08 1996-02-28 塩野義製薬株式会社 水虫治療剤
US5006346A (en) * 1988-04-28 1991-04-09 Alza Corporation Delivery system
US6005001A (en) 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US5519059A (en) * 1994-08-17 1996-05-21 Sawaya; Assad S. Antifungal formulation
US6060547A (en) * 1995-04-28 2000-05-09 The Proctor & Gamble Company Film forming foundation
AUPO379596A0 (en) * 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
CA2278328C (en) * 1998-02-09 2008-07-22 Macrochem Corporation Antifungal nail lacquer and method using same
US6143794A (en) * 1998-04-17 2000-11-07 Bertek Pharmaceuticals, Inc. Topical formulations for the treatment of nail fungal diseases
US6241360B1 (en) * 2000-03-24 2001-06-05 Daniel B. Merrell Lighted writing support and clipboard
JP4899139B2 (ja) * 2000-08-10 2012-03-21 株式会社ポーラファルマ 抗真菌医薬組成物
JP4803511B2 (ja) * 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
JP2002068975A (ja) * 2000-08-25 2002-03-08 Pola Chem Ind Inc 抗真菌医薬組成物
AU2003242235A1 (en) 2002-06-18 2003-12-31 Pola Chemical Industries Inc. Antifungal medicinal composition
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
AR045241A1 (es) * 2003-08-12 2005-10-19 Novartis Consumer Health Sa Composicion topica que comprende terbinafina e hidrocortisona
EP1627610A1 (en) * 2004-08-21 2006-02-22 TLT Medical Ltd Drug delivery throug application in nails

Also Published As

Publication number Publication date
EP1931309A2 (en) 2008-06-18
JP2009510023A (ja) 2009-03-12
US10525003B2 (en) 2020-01-07
AU2006298748B2 (en) 2010-06-03
NZ566401A (en) 2011-03-31
IL189858A0 (en) 2008-11-03
NO339414B1 (no) 2016-12-12
RU2008116311A (ru) 2009-11-10
BRPI0616765A2 (pt) 2011-06-28
PL1931309T3 (pl) 2013-02-28
US20090088434A1 (en) 2009-04-02
EP1931309B1 (en) 2012-09-26
JP5174671B2 (ja) 2013-04-03
NO20082049L (no) 2008-04-29
KR101333892B1 (ko) 2013-11-27
WO2007039533A2 (en) 2007-04-12
KR20080049797A (ko) 2008-06-04
ES2391409T3 (es) 2012-11-26
CA2623031C (en) 2014-05-13
CA2623031A1 (en) 2007-04-12
PT1931309E (pt) 2012-11-06
IL189858A (en) 2015-06-30
RU2417073C2 (ru) 2011-04-27
HK1117403A1 (en) 2009-01-16
SG166105A1 (en) 2010-11-29
WO2007039533A3 (en) 2007-08-09
AU2006298748A1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
NO2021014I1 (no) romosozumab
NO2019043I1 (no) Fremanezumab
NL300966I1 (nl) caplacizumab
NO2018013I1 (no) Opikapon
CY2013047I1 (el) Ενωσεις διαρυλυδαντοϊνης
DE602006007822D1 (de) Nrate
DE602006005805D1 (de) Verwirbelungsanordnung
DE602006021647D1 (de) Umbördelvorrichtung
DE602006018635D1 (de) Triarylcarbonsäurederivat
FI9936U1 (fi) Punnitussovitelma
DE602006019046D1 (de) Türschliesservorrichtung
NO20055686D0 (no) Sammensetning
DE502006006590D1 (de) Biozide zusammensetzungen
DK1931309T3 (da) Antimykotisk sammensætning
SE0500070L (sv) Slipklots
AT501523A3 (de) Estrich
FR2882656B1 (fr) Composition antitabagique
ATE545680T1 (de) Härtbare zusammensetzung
ATE539120T1 (de) Härtbare zusammensetzung
ATE536394T1 (de) Härtbare zusammensetzung
FI7048U1 (fi) Sahakokoonpano
UA12855S (uk) Подовжувач
UA12230S (uk) Подовжувач
ATE473232T1 (de) Carbapenemdverbindung
FI20050832A (fi) Uudet yhdisteet